Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <ul type="disc"> <li style="text-align:justify;"><em>Q1 2026 revenue of </em><em>$36.0 million</em><em> with IM8 revenue of </em><em>$33.8 million</em><em>, up </em><em>23.1%</em><em> from IM8 revenue of </em><em>$27.4 million</em><em> in Q4 2025 and nearly 6x year-over-year from IM8 revenue of </em><em>$5.7 million</em><em> in Q1 2025</em></li> <li style="text-align:justify;"><em>Raises full-year 2026 IM8 revenue guidance to $190 million to $210 million (previously $180 million to $200 million)</em></li> <li style="text-align:justify;"><em>Projects Q2 2026 revenue of $46 million to $48 million, with IM8 contributing $44 million to $46 million, representing approximately 33% sequential quarterly growth for IM8</em></li> <li style="margin-top:0in; margin-bottom:0in;"><em>Fully divested digital asset holdings for $41.3 million (510 units at ~$80,980)</em><em><br /></em></li> <li style="text-align:justify;"><em>Three new SKUs planned for Q4 2026 across Hydration, Creatine, and Kids' Gummies</em></li> <li style="text-align:justify;"><em>Appointed consumer supplements finance veteran Brian J. Rosin as Chief Financial Officer of IM8</em></li> <li style="text-align:justify;"><em>Latest investor deck can be found at <a href="https://ir.prenetics.com" title="https://ir.prenetics.com" rel="nofollow">https://ir.prenetics.com</